Nano Terra, Inc. — Department of Defense SBIR Phase II: CBD161-003
Nano Terra, Inc. — SBIR Phase II award from Department of Defense.
- Amount
- $1,096,531
- Agency
- Department of Defense · Office for Chemical and Biological Defense
- Program / Phase
- SBIR · Phase II
- Topic
- CBD161-003
- Solicitation
- 16.1
- NAICS
- —
- Place of performance
- MA
- Period
- 2022-08-29 → 2024-08-28
Description
Wounds sustained in a chemically contaminated environment are uniquely challenging to treat. Current methods include irrigation with water or a lavage solution and packing with standard gauze. These methods fail to detoxify any chemical warfare agent (CWA) present on the wound and result in a contaminated “hot” gauze which complicates safety and environmental considerations for the patient and medical personnel. Our product rapidly absorbs and detoxifies CWA, addressing this unmet need. The ultimate goal of this effort is FDA clearance of our product as a medical device.